Medicine and Dentistry
Inpatient
100%
Patient
90%
Patient with Inflammatory Bowel Disease
86%
Cohort Analysis
84%
Inflammatory Bowel Disease
45%
Crohn's Disease
34%
COVID-19
33%
Biological Product
33%
Diagnosis
26%
Biological Therapy
24%
Ulcerative Colitis
24%
Disease Course
23%
Health
18%
Combination Therapy
18%
Hospital
18%
Therapeutic Procedure
16%
Prevalence
16%
Infliximab
16%
Tumor Necrosis Factor
16%
Infection
16%
Interleukin 18
16%
Outpatient
16%
Tumor Necrosis Factor
16%
Neonates
16%
Predictor
16%
Developmental Milestone
16%
Patient Care
16%
Prospective Cohort Study
16%
Interleukin 1beta
16%
Patient Registry
16%
Obstructive Lung Disease
16%
Saquinavir
16%
Human Immunodeficiency Virus
16%
Antiretroviral Therapy
16%
Retrospective Cohort Study
16%
Colorectal Cancer
16%
Cancer Incidence
16%
Cancer Mortality
16%
Patient with Crohn's Disease
16%
Patient with Ulcerative Colitis
16%
Inflammatory Disorder
12%
Age
10%
Lamivudine/Zidovudine
10%
Odds Ratio
9%
Single Nucleotide Polymorphism
8%
Infant
7%
Biological Marker
6%
Bland-Altman Plot
6%
Consultation
6%
Follow up
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
67%
Inflammatory Bowel Disease
33%
Infliximab
33%
HIV
33%
Diseases
20%
Crohn Disease
17%
Azathioprine
16%
Corticosteroid
16%
Pharmacokinetics
16%
Monotherapy
16%
Randomized Controlled Trial
16%
Chronic Obstructive Lung Disease
16%
Inflammatory Bowel Disease
16%
Ulcerative Colitis
11%
Antibody
6%
Retrospective Study
5%